01/04/2026
Phoenix Australia is currently recruiting participants for the STOP Trial, a study investigating whether Silexan (a lavender-derived oral medication) may help reduce symptoms of Post-Traumatic Stress Disorder when added to usual treatment. Participants take either Silexan or a placebo alongside their current treatment for 12 weeks.
At Hemispheres, we are always interested in emerging evidence that may expand treatment options for people living with trauma-related conditions. Research such as this helps move the field forward by carefully evaluating new adjunctive treatments alongside established psychological therapies.
For more information about the trial, please visit Phoenix Australia:
Phoenix Australia conducts innovative research within military and veterans’ services, hospitals, health and community settings, emergency services, industry and workplace sectors and compensation environments.